Logo image
Measures of growth in children at risk for Huntington disease
Journal article   Open access   Peer reviewed

Measures of growth in children at risk for Huntington disease

Jessica K Lee, Kathy Mathews, Bradley Schlaggar, Joel Perlmutter, Jane S Paulsen, Eric Epping, Leon Burmeister and Peg Nopoulos
Neurology, Vol.79(7), pp.668-674
08/14/2012
DOI: 10.1212/WNL.0b013e3182648b65
PMCID: PMC3414667
PMID: 22815549
url
https://doi.org/10.1212/WNL.0b013e3182648b65View
Published (Version of record) Open Access

Abstract

The effect of mHTT on human development was examined by evaluating measures of growth in children at risk for Huntington disease (HD). Children at risk for HD with no manifest symptoms (no juvenile HD included) were enrolled and tested for gene expansion for research purposes only. Measurements of growth (height, weight, body mass index [BMI], and head circumference) in children tested as gene-expanded (n = 20, 7-18 years of age, CAG repeats ≥39) were compared to those of a large database of healthy children (n = 152, 7-18 years of age). Gene-expanded children had significantly lower measures of head circumference, weight, and BMI. Head circumference was abnormally low even after correcting for height, suggesting a specific deficit in brain growth, rather than a global growth abnormality. These results indicate that, compared to a control population, children who were estimated to be decades from HD diagnosis have significant differences in growth. Further, they suggest that mHTT may play a role in atypical somatic, and in particular, brain development.
Body Height - physiology Body Mass Index Humans Male Risk Cephalometry Adolescent Development - physiology Adolescent Female Child Development - physiology Body Weight - physiology Child Huntington Disease - physiopathology

Details

Metrics

Logo image